9 Nov 2018

Developing drugs for cancer and depression

From Afternoons with Jesse Mulligan, 1:21 pm on 9 November 2018

There is research being done in New Zealand to create medicines that could reduce the need for surgery and improve treatments for diseases like cancer and depression. 

The country's largest drug developer and manufacturer, Douglas Pharmaceuticals, has invested $40 million into researching and creating these drugs. 

The pharmaceutical company won a leadership prize at the New Zealand International Business Awards last night. Chief Scientific Officer Dr Peter Surman joins us to explain what health problems they're trying to tackle.

If you're interested in the trials Peter spoke about click here and here

A bottle of "PrEP" ( Pre-Exposure Prophylaxis). used to prevent HIV, on white background.

Photo: 123rf

Get the RNZ app

for easy access to all your favourite programmes

Subscribe to Afternoons with Jesse Mulligan

Podcast (MP3) Oggcast (Vorbis)